Last reviewed · How we verify
MK-8150 120 mg
At a glance
| Generic name | MK-8150 120 mg |
|---|---|
| Sponsor | Merck Sharp & Dohme LLC |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
- Headache
- Fatigue
- Postural orthostatic tachycardia syndrome
- Conjunctivitis
- Nausea
- Regurgitation
- Application site pruritus
- Common cold
- Folliculitis
- Neutrophil count increased
- White blood cell count increased
- Dizziness
Key clinical trials
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |